GL
MRK icon

Graypoint LLC’s Merck MRK Stock Holding History

Graypoint LLC’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$2.17M Sell
27,425
-3,290
-11% -$262K 0.12% 130
2025
Q1 		$2.76M Sell
30,715
-1,882
-6% -$176K 0.17% 105
2024
Q4 		$3.24M Buy
32,597
+345
+1% +$35.6K 0.2% 86
2024
Q3 		$3.66M Sell
32,252
-1,038
-3% -$123K 0.23% 76
2024
Q2 		$4.12M Sell
33,290
-4,582
-12% -$590K 0.28% 68
2024
Q1 		$5M Buy
37,872
+1,626
+4% +$200K 0.36% 60
2023
Q4 		$3.95M Buy
36,246
+842
+2% +$87.4K 0.32% 67
2023
Q3 		$3.64M Buy
35,404
+903
+3% +$97.3K 0.34% 69
2023
Q2 		$3.98M Sell
34,501
-198
-0.6% -$22.5K 0.4% 53
2023
Q1 		$3.69M Buy
34,699
+1,039
+3% +$112K 0.4% 59
2022
Q4 		$3.73M Sell
33,660
-2,017
-6% -$206K 0.45% 57
2022
Q3 		$3.07M Buy
35,677
+2,273
+7% +$203K 0.4% 65
2022
Q2 		$3.04M Sell
33,404
-1,612
-5% -$143K 0.39% 67
2022
Q1 		$2.87M Buy
35,016
+598
+2% +$47.1K 0.28% 74
2021
Q4 		$2.64M Buy
34,418
+4,055
+13% +$323K 0.28% 75
2021
Q3 		$2.28M Buy
30,363
+2,044
+7% +$155K 0.28% 74
2021
Q2 		$2.2M Sell
28,319
-1,265
-4% -$94.1K 0.29% 71
2021
Q1 		$2.18M Sell
29,584
-2,075
-7% -$153K 0.33% 66
2020
Q4 		$2.47M Sell
31,659
-2,776
-8% -$212K 0.43% 58
2020
Q3 		$2.73M Buy
34,435
+785
+2% +$61.5K 0.53% 50
2020
Q2 		$2.48M Buy
33,650
+3,251
+11% +$245K 0.57% 51
2020
Q1 		$2.23M Buy
+30,399
New +$2.39M 0.62% 49

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Graypoint LLC's MRK Position: Q2 2025 in Review

Graypoint LLC reduced its Merck (MRK) stake by 11% in Q2 2025, selling an estimated $262K and leaving 27,425 shares worth $2.17M. The position accounts for 0.12% of the portfolio, ranked #130.

Graypoint LLC first reported a position in MRK in Q1 2020 and has held it in 22 quarters since. The position peaked at $5M in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Graypoint LLC held 27,425 shares of Merck worth $2.17M as of Q2 2025.
  • Graypoint LLC sold 3,290 Merck shares in Q2 2025, an estimated $262K.
  • Merck made up 0.12% of Graypoint LLC's portfolio in Q2 2025, its #130 holding.
  • Graypoint LLC first reported a position in Merck in Q1 2020 and has held it in 22 quarters since.
  • Graypoint LLC's Merck position peaked at $5M in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.